Vitor Brunaldi MD MSc PhD

Endoscopist - Researcher - Evidence-based Medicine practitioner - Clinical Professor at USP

[Barham Abu Dayyeh MD MPH FASGE FAGA FAFS @babudayyeh]

Happy to share that Endoscopic Sleeve Gastroplasty is now an approved procedure, backed by Level I evidence and endorsed by leading endoscopy and surgical societies. IFSO’s position statement marks a major milestone for ESG. Learn more: https://t.co/EKqC83RfgQ

#MedicalInnovation #Endoscopy #Healthcare #IFSO #EndoscopicSleeveGastroplasty #Collaboration

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

It is an honor to share my comments on our recently published article looking at the efficacy and safety of ESG for overweight individuals.

Thank to my friends @MPGN46 and @babudayyeh and other collaborators.

https://t.co/qa2VSxm58Z via @GIE_Journal

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

@babudayyeh @PopovVioleta We hope this classification will help not only to guide treatment, but also to refine the surgical technique. Please, readers, share your thoughts!

[Barham Abu Dayyeh MD MPH FASGE FAGA FAFS @babudayyeh]

📊 Latest insights on post-LSG GERD. We propose a novel classification system based on enhanced pathophysiologic understandings. Share your insights as we strive for improved outcomes. #BariatricSurgery #LSG #GERD #MedicalResearch

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

@batistacarolina Tks Carol!! Would like to hear your thoughts about it as well.

[VideoGIE Journal @videogie]

VideoGIE Editor's Choice: “Endoscopic resection of a gastric GI stromal tumor using the helix-snaring technique” by Luiz Gustavo de Quadros et al. https://t.co/hRj5qDs0HY

@VBrunaldi

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

- 3y follow-up after TORe for post-RYGB patients showed redilation of the anastomosis in spite of the reduction method
- #obesity is chronic and relapsing, treatment is perennial; TORe should be repeated periodically as soon as weight gain recurs

https://t.co/gbjeTKOOuQ

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

@larissabrunaldi @YiLinMDPhD @Radhika_Bansl @MayoCancerCare So proud of you!! 👏🏻👏🏻

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

Happy and excited about having the opportunity to present a lecture and a poster as first author at @DDWMeeting this year.

I’d like to thank all my friends colleagues from @MayoClinic and @FMUSPoficial without whom this wouldn’t be possible.🙏🏻🙌🏻👏🏻

#teamworkmakesthedreamwork

[Donna-Maria Abboud @AbboudDonna]

Takeaway message from today’s GIH conference by the phenomenal Dr. Abu Dayyeh
•The Gl tract is an important target for metabolic regulation and glycemic control
•Endoscopic regenerative therapies can play a role in the management of diabetes and metabolic diseases

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

Interesting SR + MA published in @AGA_CGH reporting risk factor for early-onset CRC.
- 1st degree relative w/ CRC: RR 4.21
- Alcohol consumption: RR 1.71
- Hyperlipidemia: RR 1.62
- Obesity: RR 1.54
We should consider them to indicate colonoscopy <45yo.

https://t.co/1ikyXWbooC

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

ERCP is no time to hurry.
Biliary brushing is an important tool in the diagnostic algorithm of Malignant Strictures.
More brushing passes = better sensitivity
- 10 passes = 38%
- 20 '' = 47%
- 30 '' = 58%

Cheap and easy, costs only patience!

#GITwitter

https://t.co/3oZs7YJfQK

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

Problem is: authors employed an ultraslim endoscope which is not widely available.

Time for other more common POCS devices such as the SpyGlass to incorporate NBI.

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

NBI added significant improvement to WLI diagnostic profile during POCS for undetermined biliary strictures.

Sens: 75% x 87.5%
Spec: 82.9% x 91.4%
Accur: 82.8% x 91.3%
AUC ROC: 0.80 x 0.96 (p=0.01)

@GIE_Journal #GITwitter

https://t.co/QoUv9GcW7T

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

@amitbhattMD

Very supportive to shift our practice toward ESD as a gold-standard.

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

WESTERN DATA: ESD safer and more efficacious than EMR to address #barrettsesophagus neoplasia:

✅ En-bloc resection: 43% x 89% (p<0.001)
✅ R0 resection: 56% x 73% (p=0.01)
✅ Residual/recurrent disease: 24% x 3.5% (p<0.001)

#Cancer

https://t.co/EQ3v0n3TXM

@endoscopyjrnl

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

Preop hypoalbuminemia is associated with several negative outcomes after #bariatricsurgery
- Death: OR 1.37 (1.13-1.67)
- Pneumonia: OR 1.49 (1.31-1.69)
- VTE: OR 1.82 (1.58-2.10)
- 30-day hospitalization: OR 2.76 (2.15-3.54)

@SOARD_JOURNAL #GITwitter

https://t.co/ewJejJp6h6

[Gastroenterology @AGA_Gastro]

Patients with adenocarcinoma of the esophagus or esophagogastric junction frequently have potential screening opportunities: https://t.co/fof7aoyeKM

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

By implementing a standardized reporting system, authors increased 50% the odds of diagnosing pancreatic cancer in CTs and MRIs.

I bet the same apply to colonoscopy and CRC screening, and routine EGD.

#GITwitter #colonoscopy #science
#cancerresearch

https://t.co/vH2691g8vp

[Vitor Brunaldi MD MSc PhD @VBrunaldi]

Some old villains need reappraisal as new evidence come out: deep submucosal invasion is not an independent risk factor for LND mtx in T1 CRC.

Absolute risk: 2.6% - justifies additional surgical resection?

https://t.co/yNuxKYfI4B

@AGA_Gastro